| Janice Chen | |
| Occupation: | Chief technology officer |
| Employer: | Mammoth Biosciences |
| Relatives: | Nathan Chen (brother) |
Janice Chen is the co-founder and chief technology officer of Mammoth Biosciences, a Brisbane, California-based company founded in 2018 that is developing diagnostic tests using CRISPR.[1] [2] She received her B.S. degree from Johns Hopkins University and as a graduate student at the University of California, Berkeley, she worked in the lab of CRISPR pioneer Jennifer Doudna, receiving her PhD in Molecular and Cell Biology.[3]
Along with two of her cofounders at Mammoth Biosciences, Chen was named to the 2019 Forbes 30 Under 30 Healthcare list[4] and 2020 Business Insider's 30 Under 40 in Healthcare.[5] She was also selected to the 2020 Endpoints Top 20 Women in Biopharma,[6] and 35 Innovators Under 35 in MIT Technology Review in 2021.[7]
Chen grew up in Salt Lake City, Utah, and is one of five siblings.[8] Her youngest brother is Olympic figure skater Nathan Chen.[9] Chen's parents immigrated to the United States from China in 1988. Chen competed in chess tournaments, where she was often the youngest and the only female. Chen discovered her love of science at her father's biotech business in Utah.
In 2017, Chen and fellow Berkeley classmate and researcher Lucas Harrington, along with their doctoral advisor, Nobel laureate and Berkeley professor Jennifer Doudna, founded Mammoth Biosciences at a biotech incubator in the Dogpatch neighborhood of San Francisco. In September 2021, Mammoth – now in a state-of-the-art facility in Brisbane, California – completed its seventh round of funding, raising US$195 million at a valuation of over US$1 billion.